Wayne Rothbaum News Today

Key Insights Given the large stake in the stock by institutions, Iovance Biotherapeutics' stock price might be...

The stock markets generate an immense flood of raw data, a glut of information that presents a barrier to the average investor. How to sort through it, to find the right stocks to buy? What’s needed is some clear signal, something that can find some sensible patter in the results of millions of daily stock transactions. Fortunately, there are plenty of such signals out there. Purchases from the corporate insiders are generally seen as one of the clearest. The reason is simple. Corporate i...

In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the boon for countless cancer patients.

Iovance Biotherapeutics, Inc. (IOVA) shares are gaining more than 12 percent on Monday morning trade on reports that its independent director Wayne Rothbaum bought 28 percent more shares at an average price of $5.

The company's stock rally began on Friday.

Forbes 37th annual list of the worlds richest people in 2023 includes 35 entrepreneurs, heirs, inventors and leaders from healthcare.  

Nathan Vardi’s “For Blood and Money” shows how stock traders funded the race to develop two rival blood cancer drugs.

U.S. stocks traded lower this morning, with the Dow Jones falling around 250 points on Monday. Following the market opening Monday, the Dow trade...

Several insiders have been purchasing the company's common shares lately.